�
LONDON,
UNITED KINGDOM - Media OutReach - 28 March 2019 - Cancer is the world’s second biggest killer, responsible
for 9.6m deaths in 2018–roughly one out of six across the globe–and the leading
or second largest cause of mortality before the age of 70 in over half the
world’s countries. Amid demographic changes such as population ageing, cancer
incidence is set to rise by 63% between 2018 and 2040, according to the
International Agency for Research on Cancer. A new report by The Economist
Intelligence Unit looks at the complexities of this growing menace and at
whether the world is ready to face it.
Cancer preparedness around the world:
National readiness for a global epidemic,
funded with support from Novartis,
Pfizer and Roche, introduces the Index of Cancer Preparedness (ICP),
which draws on a wide range of data relevant to cancer policy and control from
28 countries. The aims of the ICP are to allow benchmarking of national efforts
and, even more, to initiate discussion on best practice in addressing the
cancer challenge. Australia tops the ICP, followed by the Netherlands and
Germany. Saudi Arabia, Romania and Egypt face the largest room for improvement.
The ICP explores
the issue of cancer preparedness through three broad domains:
The index shows
that the highest scores on average are found in policy and planning. However,
the countries’ performances get weaker when moving from policy to
implementation to overall health system readiness and governance. This is
particularly the case in middle- and low-income countries.
The report
identifies the four essentials of cancer preparedness. First, essential
investment refers to appropriate spending and resources dedicated to cancer
care. Second essential roadmap refers to effective planning, especially via
national cancer control plans. Third, essential foundation refers to the need
to embed cancer control in an accessible, general health system. And fourth,
essential intelligence refers to the need to measure the nature of the
challenge as well as how well interventions are working, for example via
population-based cancer registries.
Martin Koehring, managing editor at the EIU, added: “No health system,
no government and no society can afford a lukewarm response to cancer. This
group of diseases is already the world’s second biggest killer and costs the
global economy upwards of US$1trn per year. The ICP is a useful benchmarking
tool to help policymakers and other key stakeholders to identify where their
countries stand in cancer control compared with their peers and how they can
boost their preparedness.”
View the index results and read the
accompanying white paper
The content of
this report is solely the responsibility of the Economist Intelligence Unit and
the views expressed are not necessarily those of any of the sponsors.
The
EIU is the thought leadership, research and analysis division of The Economist
Group and the world leader in global business intelligence for executives. We
uncover novel and forward-looking perspectives with access to over 650 expert
analysts and editors across 200 countries worldwide. More information can be
found on www.eiuperspectives.economist.com. Follow us on Twitter, LinkedIn, and Facebook
Strategic alliance poised to create new growth avenues in Thailand, Japan, and beyond. BANGKOK, THAILAND…
Leonteq announced today that it has enabled its Shari’a-compliant structured product offering on its digital…
Revolutionizing Home and Commercial Cleaning with Aqueous Ozone Solutions that are hypoallergenic & eco-friendly QUEENSLAND,…
Enjoy up to 10% rebate and chance to win business class round trip to Tokyo…
BANGKOK, THAILAND - Media OutReach Newswire - 5 November 2024 - Indorama Ventures Public Company…
KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 5 November 2024 - As the Public…